 | | Vol. 15.15 – 27 April, 2023 |
| |
|
|
| Human-induced pluripotent stem cells were established from three different hematopoietic stem cell sources—peripheral blood, cord blood, and bone marrow aspirates— using episomal reprogramming vectors and differentiated into functionalred blood cells.
[Stem Cell Research & Therapy] |
|  |
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The proliferative, clonogenic, multilineage differentiation, and extracellular matrix synthesis capacities o fhuman umbilical cord perivascular cells were evaluated in a commercial serum- and xeno-free culture medium on tissue culture polystyrene and benchmarked to adult bone marrow-derived MSCs.
[Stem Cell Research & Therapy] |
|
|
|
| The authors used the epithelial-mesenchymal transition (EMT) model in MLE-12 cells and observed the effects and mechanism of human umbilical cord MSCs (HucMSC)-derived extracellular vesicles inhibition of EMT.
[Ecotoxicology And Environmental Safety] |
|
|
|
| Scientists investigated the capacity of spontaneously forming stem cell spheroids from cultured Wharton’s Jelly stromal cells in regard to their neuronal differentiation potential, and compared them to undifferentiated spheroids or adherent MSCs.
[Stem Cell Reviews And Reports] |
|
|
|
| Investigators compared longitudinal quality of life (QOL) measures between double umbilical cord blood transplants and haploidentical bone marrow transplants and investigated the association of QOL and clinical outcomes.
[Transplantation And Cellular Therapy] |
|
|
|
| Researchers found that conditioned medium of human amniotic mesenchymal stem cells treatment suppressed lipopolysaccharide-induced activation of MAPK and NF-κB pathways by inhibiting CD14/TLR4 in THP-1 cells.
[Molecular Immunology] |
|  |
|
|
|
| The authors review the latest research findings and their significance in the context of understanding the development of the human placenta and how associated disorders are related to common pregnancy complications.
[Proceedings Of The Royal Society B-Biological Sciences] |
|
|
|
| Scientists assess different options of umbilical cord blood banking and whether hybrid banking could be a valuable alternative to the existing public and private cord blood banking models.
[Archives Of Gynecology And Obstetrics] |
|
|
|
|
| The biotech startup Immune Bridge has bagged $12 million in a seed financing round to drive the development of natural killer cells that can be used in cell therapies for cancer.
[BioPharmaReporter] |
|
|
|
|
| June 2 – 6, 2023
Chicago, Illinois, United States |
|
|
|
|
|
| | University of Texas MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| | Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| | Université de Lausanne – Lausanne, Switzerland |
|
|
|
| | Medical College of Wisconsin – Milwaukee, Wisconsin, United States |
|
|
|
| | Medical College of Wisconsin – Milwaukee, Wisconsin, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
